Skip to main content

Advertisement

SpringerLink
Log in

Associations among Lipids, Leptin, and Leptin Receptor Gene Gin223Arg Polymorphisms and Breast Cancer in China

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

We evaluated the relationship among the leptin receptor (LEPR) gene Gln223Arg polymorphism, body mass index (BMI), waist and hip circumference ratio (WHR), dietary structure, lifestyle, and other biomarkers with breast cancer and determined whether they could be effective for the prevention and treatment of breast cancer. The Gln223Arg polymorphisms in the LEPR gene were investigated in blood deoxyribonucleic acid (DNA) available for 240 breast cancer cases and 500 controls. Genotyping was performed by polymerase chain reaction–restriction fragment length polymorphism. Leptin, insulin were determined by enzyme-linked immunosorbent assays. We found that the serum levels of leptin, insulin, triglyceride (TG), free cholesterol (FCH), apolipoprotain (APO) A1, and BMI were significantly higher in breast cancer cases than the controls, while physical activity was clearly less in breast cancer cases (P < 0.02 ~ P < 0.001, respectively). Moreover, there were significant association between the Gln223Arg genotype and breast cancer risk; homozygotes for AA and heterozygotes for AG,AG + GG genotypes had been proved to increase the risk of breast cancer, and their corresponding odds ratio were 7.14 (95% confidence interval [CI] = 1.92–25.64), 1.33(95% CI = 1.03–2.70), and 2.04 (95% CI = 1.09–3.82). Interestingly, logistic regression analysis showed that LEPR gene Gln223Arg polymorphism and elevated leptin, insulin, TG, FCH, APOA1, WHR, and reduced APOB increased the risk of developing breast cancer, respectively. And, it also suggested that LEPR gene Gln223Arg polymorphisms, elevated leptin, insulin, TG, FCH, APOA1, WHR, and reduced APOB should play a major role in the development of breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Xu GW (2005) Chinese breast cancer deaths jump 40% since one child abortion policy. Life Site News, October 13 (Beijing)

  2. Shu X, Jin F, Dai Q, Rong J, Shi JR, Potter JD, Brinton LA, Hebert JR, Ruan ZX, Gao YT, Zheng W (2001) Association of body size and fat distribution with risk breast cancer among Chinese women. Int J Cancer 94:499–454

    Article  Google Scholar 

  3. Lorincz AM, Sukumar S (2006) Molecular links between obesity and breast cancer. Endocr Relat Cancer 13:279–292

    Article  PubMed  CAS  Google Scholar 

  4. Berclaz G, Li S, Price KN et al (2004) Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol 15:875–884

    Article  PubMed  CAS  Google Scholar 

  5. Asseryanis A, Ruecklinger E, Hellan M, Kubista E, Singer CF (2004) Breast cancer size in postmenopausal women is correlated with body mass index and androgen serum levels. Gynecol Endocrinol 18:29–36

    Article  PubMed  CAS  Google Scholar 

  6. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638

    Article  PubMed  Google Scholar 

  7. Hu X, Juneja SC, Maihle NJ, Cleary MP (2002) Leptin—a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 94:1704–1711

    PubMed  CAS  Google Scholar 

  8. Laud K, Gourdou I, Pessemesse L, Peyrat JP, Djiane J (2002) Identification of leptin receptor in human breast cancer: functional activity in the T47-D breast cancer cell line. Mol Cell Endocrinol 188:219–226

    Article  PubMed  CAS  Google Scholar 

  9. O’Brien SN, Welter BH, Price TM, Clemson U, Glemson SG (1999) Presence of leptin in breast cell lines and breast tumors. Biochem Biophys Res Commun 259:695–698

    Article  PubMed  CAS  Google Scholar 

  10. Han CZ, Zhang XT, Du LL, Lui XY, Jing JX, Zhao XW, Yang X, Tian BG (2005) Serum levels of leptin, insulin, and lipids in relation to breast cancer in China. Endocrine 26:19–24

    Article  PubMed  CAS  Google Scholar 

  11. Tessitore L, Vizio B, Jenkins O, De Stefano I et al (2000) Leptin expression in colorectal and breast cancer patients. Int J Mol Med 5:421–426

    PubMed  CAS  Google Scholar 

  12. Stattin P, Lukanova A, Biessy C, Soderberg S, Palmqvist R, Kaaks R, Olsson T, Jellum E (2004) Obesity and colon cancer: does leptin provide a link? Int J Cancer 109:149–152

    Article  PubMed  CAS  Google Scholar 

  13. Ribeiro R, Lopes C, Medeiros R (2006) The link between obesity and prostate cancer: the leptin pathway and therapeutic perspectives. Prostate Cancer Prostatic Dis 9:19–24

    Article  PubMed  CAS  Google Scholar 

  14. Malik KF, Young WS 3rd (1996) Localization of binding sites in the central nervous system for leptin (OB protein) in normal, obese (ob/ob), and diabetic (db/db) C57BL/6J mice. Endocrinology 137:1497–500

    Article  PubMed  CAS  Google Scholar 

  15. Tsuchiya T, Shimizu H, Hori T, Mori M (1999) Expression of leptin receptor in lung: leptin as a growth factor. Eur J Pharmacol 365:273–279

    Article  PubMed  CAS  Google Scholar 

  16. Mix H, Widjaja A, Jandl O, Cornberg M, Kaul A, Goke M, Beil W, Kuske M, Brabant G, Manns MP, Wagner S (2000) Expression of leptin receptor isoforms in the human stomach. Gut 47:481–486

    Article  PubMed  CAS  Google Scholar 

  17. Hino M, Nakano T, Yamane T, Ohta K, Takubo T, Tatsumi N (2000) Leptin receptor and leukemia. Leuk Lymphoma 36:457–461

    Article  PubMed  CAS  Google Scholar 

  18. Hardwick JC, Van Den Brink GR, Offerhaus GJ, Van Deventer SJ, Peppelenbosch MP (2001) Leptin is a growth factor for colonic epithelial cells. Gastroenterology 121:79–90

    Article  PubMed  CAS  Google Scholar 

  19. Attoub S, Noe V, Pirola L, Bruyneel E, Chastre E, Mareel M, Wymann MP, Gespach C (2000) Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-and rac-dependent signaling pathways. FASEB J 14:2329–2338

    Article  PubMed  CAS  Google Scholar 

  20. Isono M, Inoue R, Kamida T, Kobayashi H, Matsuyama J (2003) Significance of leptin expression in invasive potential of pituitary adenomas. Clin Neurol Neurosurg 105:111–116

    Article  PubMed  Google Scholar 

  21. Zheng YM, Xiang KS, Zhang R, Jia WP, Lu JS, Tong JL (1999) Association of Gln223Arg variant in leptin receptor gene with metabolic abnormalities and hypertension in type 2 diabetes in Shanghai “Han” population. Chinese Journal of Endocrinology and metabolism 38:174–178

    CAS  Google Scholar 

  22. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638

    Article  PubMed  Google Scholar 

  23. Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3:565–574

    Article  PubMed  Google Scholar 

  24. Tessitore L, Visio B, Pesola D, Cecchini F, Mussa A, Argiles JM, Benedetto C (2004) Adipocytes expression and circulating levels of leptin increase in both gynaecological and breast cancer patients. Int J Cancer 24:1529–1535

    CAS  Google Scholar 

  25. Ozet A, Arpaci F, Yilmaz llker M, Ayta H, Ozturk B, Komurcu S, Yavuz AA, Tezcan Y, Acikel C (2001) Effect of tamoxifen on the serum leptin level in patients with breast cancer. Jpn J Clin Oncol 31:424–427

    Article  PubMed  CAS  Google Scholar 

  26. Christo S, Bolhke K, Moschos S, Cramer W (1999) Leptin in relation to carcinoma in situ of the breast: a study of pre-menopausal cases and controls. Int J Cancer 80:523–526

    Article  Google Scholar 

  27. Makoto I, Joji K, Hirokazu N (2004) Enhanced expression of leptin and leptin receptor (LEPR) in human breast cancer. Clin Cancer Res 10:4325–4331

    Article  Google Scholar 

  28. Smith-Kirwin SM, O’Connor DM, Johnston J, de Lancy E, Hassink SG, Funanage VL (1998) Leptin expression in human mammary epithelial cells and breast milk. J Clin Endocrinol Metab 83:1810–1813

    Article  PubMed  CAS  Google Scholar 

  29. Waxler SH, Taber P, Melcher LP (1953) Obesity and the time of appearance of spontaneous mammary carcinoma in C3H mice. Cancer Res 13:276–278

    PubMed  CAS  Google Scholar 

  30. Heston WE, Vlahakis G (1962) Genetic obesity and neoplasia. J Natl Cancer Inst (Bethesda) 29:197–209

    CAS  Google Scholar 

  31. Cleary MP, Phillip FC, Getzin SC, Jacobson TL, Jacobson MK, Christensen TA, Juneja SC, Grande JP, Maihle NJ (2003) Genetically obese MMTV-TGF-alph/Lep(ob) Lep(ob) female mice do not develop mammary tumors. Breast Cancer Res Treat 77:205–215

    Article  PubMed  CAS  Google Scholar 

  32. Mantzoros CS, Bolhke K, Moschos S, Cramer CS (1999) Leptin in relation to carcinoma in situ of the breast: a study of pre-menopausal cases and controls. Int J Cancer 80:523–526

    Article  PubMed  CAS  Google Scholar 

  33. Petridou E, Papadiamantis Y, Markopoulos C, Spanos E, Dessypris N, Trichopoulos D (2000) Leptin and insulin growth factor I in relation to breast cancer. Cancer Causes Control 11:383–388

    Article  PubMed  CAS  Google Scholar 

  34. Friedman JM, Leibel RL, Siegel DS, Walsh J, Bahary N (1991) Molecular mapping of the mouse ob mutation. Genomics 11:1054–1062

    Article  PubMed  CAS  Google Scholar 

  35. Coleman DL (1978) Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14:141–148

    Article  PubMed  CAS  Google Scholar 

  36. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372:425–432

    Article  PubMed  CAS  Google Scholar 

  37. Mammes O, Betoulle D, Aubert R, Herbeth B, Siest G, Fumeron F (2000) Association of the G-2548A polymorphism in the 5′ region of the LEP gene with overweight. Ann Hum Genet 64:391–394

    Article  PubMed  CAS  Google Scholar 

  38. Mattevi VS, Zembrzuski VM, Hutz MH (2002) Association analysis of genes involved in the leptin-signaling pathway with obesity in Brazil. Int J Obes Relat Metab Disord 26:1179–1185

    Article  PubMed  CAS  Google Scholar 

  39. Hager J, Clement K, Francke S, Raison J, Lahlou N, Rich N, Pelloux V, Basdevant A, GuyGrand B, North M, Froguel P (1998) A polymorphism in the 5′ untranslated region of the human ob gene is associated with low leptin levels. Int J Obes Relat Metab Disord 22:200–205

    Article  PubMed  CAS  Google Scholar 

  40. Lamas O, Marti A, Martinez JA (2002) Obesity and immunocompetence. Eur J Clin Nutr 56(3):S42–S45

    Article  PubMed  Google Scholar 

  41. Gotoda T, Manning BS, Goldstone AP, Imrie H, Evans AL, Strosberg AD, McKeigue PM, Scott J, Aitman TJ (1997) Leptin receptor gene variation and obesity: lack of association in a white British male population. Hum Mol Genet 6:869–876

    Article  PubMed  CAS  Google Scholar 

  42. Yiannakouris N, Yannakoulia M, Melistas L, Chan JL, Klimis-Zacas D, Mantzoros CS (2001) The Q223R polymorphism of the leptin receptor gene is significantly associated with obesity and predicts a small percentage of body weight and body composition variability. J Clin Endocrinol Metab 86:4434–4439

    Article  PubMed  CAS  Google Scholar 

  43. Hoffstedt J, Eriksson P, Mottagui-Tabar S, Arner P (2002) A polymorphism in the leptin promoter region (−2548 G/A) influences gene expression and adipose tissue secretion of leptin. Horm Metab Res 34:355–359

    Article  PubMed  CAS  Google Scholar 

  44. Snoussi K, Strosberg AD, Bouaouina N, Ahmed SB, Helal AN, Chouchane L (2006) Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma. BMC Cancer 6:38–51

    Article  PubMed  Google Scholar 

  45. Woo HY, Park H, Ki CS, Park YL, Bae WG (2005) Relationships among serum leptin, leptin receptor gene polymorphisms, and breast cancer in Korea. Cancer Lett 9:1–6

    Google Scholar 

  46. Jerome L, Shiry L, Leyland JB (2004) Anti-insulin-like growth factor strategies in breast cancer. Semin Oncol 31:54–63

    Article  PubMed  CAS  Google Scholar 

  47. Allen NE, Appleby PN, Kaaks R, Rinaldi S, Davey GK, Key TJ (2003) Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women. Cancer Causes Control 14:65–74

    Article  PubMed  Google Scholar 

  48. Zefang R, Qiuyin C, Xiao-Ou S, Hui C, Chun LI, Herbert YU, Yu-Tang G, Wei Z (2004) Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP3 protein levels among Chinese women. Cancer Epidemiol Biomark Prev 13:1290–1295

    Google Scholar 

  49. Takahashi Yasuno A, Masuzaki H, Miyawaki T, Ogawa Y, Matsuaka N, Hosoda K, Inoue G, Yoshimasa Y, Nakao K (2003) Leptin receptor polymorphism is association with serum lipids levels and impairment of cholesterol lowering effect in Japanese men. Diabetes Res Clin Pract 62:169–175

    Article  PubMed  CAS  Google Scholar 

  50. Coskun U, Gunel N, Torunner FB et al (2003) Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer. Neoplasma 50:41–46

    PubMed  CAS  Google Scholar 

  51. Du L-L, Han C-Z, Liu X-Y et al (2006) Relationship between serum leptin level BMI and breast cancer incidence. Cancer Res Clin 18:307–310

    CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by grants from Board of Health of Shanxi Province (200413) and Science and Technology Committee of Shanxi Province (2006011129).

Author information

Authors and Affiliations

  1. Department of Etiology, Shanxi Cancer Institute, Taiyuan, 030013, China

    Cun-Zhi Han, Li-Li Du, Jie-Xian Jing, Xian-Wen Zhao & Bao-Guo Tian

  2. Department of Galactophore Surgery, Shanxi Cancer Hospital, Taiyuan, 030013, China

    Fu-Guo Tian

  3. Shanxi Medical University, Taiyuan, 030013, China

    Jing Shi

  4. Shanxi Cancer Hospital, Taiyuan, 030013, China

    Xiu-Ying Liu & Li-Jiao Zhang

Authors
  1. Cun-Zhi Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Li-Li Du
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jie-Xian Jing
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xian-Wen Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fu-Guo Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jing Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bao-Guo Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Xiu-Ying Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Li-Jiao Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cun-Zhi Han.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Han, CZ., Du, LL., Jing, JX. et al. Associations among Lipids, Leptin, and Leptin Receptor Gene Gin223Arg Polymorphisms and Breast Cancer in China. Biol Trace Elem Res 126, 38–48 (2008). https://doi.org/10.1007/s12011-008-8182-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12011-008-8182-z

Keywords

Search

Navigation